Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455.
Proc Natl Acad Sci U S A. 2023 Nov 28;120(48):e2313755120. doi: 10.1073/pnas.2313755120. Epub 2023 Nov 20.
The complex, systemic pathology of sickle cell disease is driven by multiple mechanisms including red blood cells (RBCs) stiffened by polymerized fibers of deoxygenated sickle hemoglobin. A critical step toward understanding the pathologic role of polymer-containing RBCs is quantifying the biophysical changes in these cells in physiologically relevant oxygen environments. We have developed a microfluidic platform capable of simultaneously measuring single RBC deformability and oxygen saturation under controlled oxygen and shear stress. We found that RBCs with detectable amounts of polymer have decreased oxygen affinity and decreased deformability. Surprisingly, the deformability of the polymer-containing cells is oxygen-independent, while the fraction of these cells increases as oxygen decreases. We also find that some fraction of these cells is present at most physiologic oxygen tensions, suggesting a role for these cells in the systemic pathologies. Additionally, the ability to measure these pathological cells should provide clearer targets for evaluating therapies.
镰状细胞病的复杂系统性病理学是由多种机制驱动的,包括由脱氧镰状血红蛋白聚合纤维使红细胞(RBC)变硬。理解含聚合物 RBC 的病理作用的关键步骤是在生理相关的氧环境中定量测量这些细胞的生物物理变化。我们开发了一种微流控平台,能够在受控氧和剪切应力下同时测量单个 RBC 的变形性和氧饱和度。我们发现,具有可检测量聚合物的 RBC 降低了氧亲和力和变形性。令人惊讶的是,含聚合物细胞的变形性是与氧无关的,而这些细胞的分数随着氧的减少而增加。我们还发现,在大多数生理氧张力下,这些细胞的一部分存在,这表明这些细胞在系统性病理中起作用。此外,测量这些病理细胞的能力应该为评估治疗方法提供更明确的目标。